M05.05 Felty's syndrome, hip

Name of the Condition

• Felty's syndrome, hip

Summary

Felty's syndrome is a rare complication of rheumatoid arthritis characterized by the triad of rheumatoid arthritis, splenomegaly (enlarged spleen), and neutropenia (low neutrophil count). When affecting the hip, it involves chronic inflammation of the hip joint alongside systemic manifestations. The condition typically occurs in individuals with long-standing, severe rheumatoid arthritis and is associated with increased susceptibility to infections due to neutropenia.

Causes

Felty's syndrome is considered a variant of rheumatoid arthritis, though its exact cause is not fully understood. It is thought to result from chronic inflammation and immune dysregulation, leading to splenic sequestration of neutrophils and bone marrow suppression. The condition is strongly associated with high titers of rheumatoid factor and anti-citrullinated protein antibodies (ACPA). Hip involvement occurs as part of the broader rheumatoid arthritis process affecting multiple joints.

Risk Factors

• Long-standing, severe rheumatoid arthritis
• High titers of rheumatoid factor
• Presence of anti-citrullinated protein antibodies (ACPA)
• Advanced age (typically over 50 years)
• Female gender (more commonly affected)

Symptoms

• Persistent joint pain, swelling, and stiffness in the hip from underlying rheumatoid arthritis
• Fatigue and weakness
• Recurrent infections due to neutropenia
• Abdominal discomfort or fullness from splenomegaly
• Unexplained weight loss
• Skin discoloration or ulcers (less common)

Diagnosis

Diagnosis of Felty's syndrome, hip, requires confirmation of the triad of rheumatoid arthritis, splenomegaly, and neutropenia, with hip involvement documented. Clinical evaluation includes assessment of joint symptoms, splenic size, and blood counts. Laboratory tests may show neutropenia, anemia, or thrombocytopenia. Imaging of the hip (e.g., X-ray, MRI) can assess joint damage. Rheumatoid factor and anti-citrullinated protein antibodies are typically elevated. Bone marrow biopsy may be considered if bone marrow suppression is suspected.

Treatment Options

Treatment focuses on managing rheumatoid arthritis and its complications. Disease-modifying antirheumatic drugs (DMARDs) or biologics may control joint inflammation. Granulocyte colony-stimulating factor (G-CSF) can address neutropenia. Splenectomy is rarely performed. Infections require prompt treatment. Hip-specific interventions, such as physical therapy or joint replacement, may be needed for severe joint damage.

Prognosis and Follow-Up

Prognosis depends on disease severity and response to treatment. Early intervention can improve outcomes, but long-standing disease may lead to persistent joint damage or infections. Regular monitoring of blood counts, joint function, and infection risk is essential. Follow-up includes rheumatology and hematology evaluations to adjust therapies and address complications.

Complications

• Increased risk of serious infections due to neutropenia
• Severe joint damage in the hip, potentially requiring surgery
• Anemia or thrombocytopenia from bone marrow involvement
• Splenic rupture (rare)
• Accelerated rheumatoid arthritis progression

Lifestyle & Prevention

• Maintain joint mobility through gentle exercise and physical therapy
• Practice good hygiene to reduce infection risk
• Follow rheumatoid arthritis treatment plans consistently
• Monitor for signs of infection or joint changes
• Avoid smoking, which may worsen rheumatoid arthritis

When to Seek Professional Help

Seek care if experiencing:

• Worsening hip pain, swelling, or stiffness
• Recurrent or severe infections
• Unexplained fever or fatigue
• Abdominal pain or fullness (possible splenomegaly)
• Signs of infection (e.g., chills, pus, or non-healing wounds)

Tips for Medical Coders

Document the presence of Felty's syndrome with hip involvement, including confirmation of rheumatoid arthritis, splenomegaly, and neutropenia. Specify hip involvement to justify the code M05.05. Ensure clinical documentation supports the triad and hip-specific symptoms or findings. Code as a complication of rheumatoid arthritis, not a standalone condition.